Related Experiment Video
Updated: Jun 1, 2026

Quantitative PCR-based Assay to Measure Sonic Hedgehog Signaling in Cellular Model of Ciliogenesis
Published on: January 31, 2025
GLI1-dependent transcriptional repression of CYLD in basal cell carcinoma
S Kuphal1, G Shaw-Hallgren, M Eberl
1Institute of Pathology, University of Regensburg, Germany.
Abstract:
CYLD is a deubiquitination enzyme that regulates different cellular processes, such as cell proliferation and cell survival. Mutation and loss of heterozygosity of the CYLD gene causes development of cylindromatosis, a benign tumour originating from the skin. Our study shows that CYLD expression is dramatically downregulated in basal cell carcinoma (BCC), the most common cancer in humans. Reduced CYLD expression in basal cell carcinoma was mediated by GLI1-dependent activation of the transcriptional repressor Snail. Inhibition of GLI1 restored the CYLD expression-mediated Snail signaling pathway, and caused a significant delay in the G1 to S phase transition, as well as proliferation. Our data suggest that GLI1-mediated suppression of CYLD has a significant role in basal cell carcinoma progression.
Insights
The study reveals that reduced CYLD expression in basal cell carcinoma (BCC) is driven by GLI1, which suppresses CYLD. Inhibiting GLI1 restores CYLD, hindering BCC progression.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- CYLD is a deubiquitination enzyme regulating cell proliferation and survival.
- CYLD gene mutations are linked to cylindromatosis, a skin tumor.
- Basal cell carcinoma (BCC) is the most common human cancer.
Purpose of the Study:
- To investigate the role of CYLD in basal cell carcinoma (BCC).
- To elucidate the mechanism of CYLD downregulation in BCC.
- To explore the therapeutic potential of targeting the GLI1-CYLD pathway in BCC.
Main Methods:
- Quantitative analysis of CYLD expression in BCC tissues.
- Investigation of GLI1 and Snail interactions using molecular biology techniques.
- Inhibition of GLI1 signaling pathway in BCC models.
- Assessment of cell cycle progression and proliferation rates.
Main Results:
- CYLD expression is significantly downregulated in BCC.
- GLI1 directly activates the transcriptional repressor Snail, leading to reduced CYLD expression.
- Inhibition of GLI1 restores CYLD expression and the Snail signaling pathway.
- GLI1 inhibition delays cell cycle transition from G1 to S phase and reduces proliferation.
Conclusions:
- GLI1-mediated suppression of CYLD is a key mechanism in BCC progression.
- Targeting the GLI1-CYLD axis offers a potential therapeutic strategy for BCC.
- Restoring CYLD expression may inhibit BCC cell proliferation and tumor development.
Related Concept Videos
Inhibition of Cdk Activity
Inhibition of CDK Activity
Abnormal Proliferation
Negative Regulator Molecules
Hedgehog Signaling Pathway
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...